N
SBRA icon

Natixis’s Sabra Healthcare REIT SBRA Stock Holding History

Natixis’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-44,906
Closed -$778K – 1168
2024
Q4 		$778K Buy
44,906
+9,836
+28% +$180K ﹤0.01% 641
2024
Q3 		$653K Sell
35,070
-2,179
-6% -$36.7K ﹤0.01% 598
2024
Q2 		$574K Sell
37,249
-5,636
-13% -$80.5K ﹤0.01% 590
2024
Q1 		$633K Buy
+42,885
New +$594K ﹤0.01% 588
2022
Q4 		– Sell
-95,400
Closed -$1.25M – 1322
2022
Q3 		$1.25M Sell
95,400
-97,001
-50% -$1.43M 0.01% 711
2022
Q2 		$2.69M Buy
+192,401
New +$2.57M 0.01% 597
2022
Q1 		– Sell
-99,601
Closed -$1.35M – 1312
2021
Q4 		$1.35M Buy
+99,601
New +$1.41M ﹤0.01% 867
2018
Q3 		– Sell
-10,081
Closed -$219K – 949
2018
Q2 		$219K Sell
10,081
-4,421
-30% -$86.3K ﹤0.01% 809
2018
Q1 		$256K Buy
14,502
+862
+6% +$15.2K ﹤0.01% 778
2017
Q4 		$256K Sell
13,640
-17,010
-55% -$338K ﹤0.01% 723
2017
Q3 		$672K Buy
+30,650
New +$692K 0.01% 594

Other funds holding SBRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Natixis's SBRA Position: Q1 2025 in Review

Natixis sold out of Sabra Healthcare REIT (SBRA) in Q1 2025, closing a stake of 44,906 shares — an estimated $778K sold.

Natixis first reported a position in SBRA in Q3 2017 and held it in 11 quarters. The position peaked at $2.69M in Q2 2022. 403 funds tracked by Wall St. Rank hold SBRA as of Q1 2025.

  • Natixis reported no remaining Sabra Healthcare REIT position as of Q1 2025 after selling out during the quarter.
  • Natixis sold 44,906 Sabra Healthcare REIT shares in Q1 2025, an estimated $778K.
  • Natixis first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 11 quarters.
  • Natixis's Sabra Healthcare REIT position peaked at $2.69M in Q2 2022.
  • 403 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2025.

Based on Natixis's 13F filing for Q1 2025, filed 14 May 2025.